Sidam will join both the European Congress of Radiology (ECR) that will be held in Vienna from February 28th to March 4th, 2018 (stand X4 406) and the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels from March 20th to March 23th, 2018 (stand 1.30).
The company has won the 'Imprese X Innovazione - Andrea Pininfarina Award’, assigned by Confindustria for having successfully invested in research and innovation.
This is the first innovation award in Europe to have adopted the parameters of the European Foundation for Quality Management (EFQM) and participates, for the Industry and Services category, to the Prize of Prizes, an award set up by the President of the Council of Ministers on a mandate by the President of the Italian Republic.
The European Radiology Congress - ECR 2017 (Wien, 1/5 march 2017) it’s the most important event in the continent, the second worldwide and Sidam can’t miss it. It’s a trend setting, dynamic environment where leading companies of the sector are taking the opportunity to discuss and present the latest technology progresses of the industry, with a particular focus on the newest generation of radiology professionals.
We acquired a 75% stake in BTC Medical Europe, leader company in the postoperative blood recovery and oncology sectors and based in Valeggio sul Mincio (VR) and in Nonantola (MO).
The goal is to establish an entirely Italian biomedical centre and to enhance our portfolio of products and markets.
Another important milestone reached by Sidam: Mirandola's production site obtained from FDA (Food and Drug Administration) the Registration Number, which qualifies the company as a production workshop authorized to produce for the United States of America. This certification ensures, also for the North American market, the safety and efficacy of biomedical devices produced by the company, already recognized by the various awarding bodies responsible for Europe, South America and Asia. This recognition will allow Sidam to significantly expand its international business opportunities in the biomedical sector.